Your browser doesn't support javascript.
loading
Multiply Guaranteed Catalytic DNA Circuit for Cancer-Cell-Selective Imaging of miRNA and Robust Evaluation of Drug Resistance.
Wang, Zeyue; Shang, Yu; Zhu, Yuxuan; He, Yuqiu; Chen, Yingying; Liu, Xiaoqing; Wang, Fuan.
Afiliação
  • Wang Z; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • Shang Y; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • Zhu Y; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • He Y; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • Chen Y; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • Liu X; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
  • Wang F; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, P. R. China.
Anal Chem ; 96(14): 5560-5569, 2024 04 09.
Article em En | MEDLINE | ID: mdl-38529650
ABSTRACT
Catalytic DNA circuits are desirable for sensitive bioimaging in living cells; yet, it remains a challenge to monitor these intricate signal communications because of the uncontrolled circuitry leakage and insufficient cell selectivity. Herein, a simple yet powerful DNA-repairing enzyme (APE1) activation strategy is introduced to achieve the site-specific exposure of a catalytic DNA circuit for realizing the selectively amplified imaging of intracellular microRNA and robust evaluation of the APE1-involved drug resistance. Specifically, the circuitry reactants are firmly blocked by the enzyme recognition/cleavage site to prevent undesirable off-site circuitry leakage. The caged DNA circuit has no target-sensing activity until its circuitry components are activated via the enzyme-mediated structural reconstitution and finally transduces the amplified fluorescence signal within the miRNA stimulation. The designed DNA circuit demonstrates an enhanced signal-to-background ratio of miRNA assay as compared with the conventional DNA circuit and enables the cancer-cell-selective imaging of miRNA. In addition, it shows robust sensing performance in visualizing the APE1-mediated chemoresistance in living cells, which is anticipated to achieve in-depth clinical diagnosis and chemotherapy research.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article